Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1985 Apr;82(8):2483–2487. doi: 10.1073/pnas.82.8.2483

Rationale for bone marrow transplantation in the treatment of autoimmune diseases.

S Ikehara, R A Good, T Nakamura, K Sekita, S Inoue, M M Oo, E Muso, K Ogawa, Y Hamashima
PMCID: PMC397583  PMID: 3887403

Abstract

Transplantation of normal bone marrow from C3H/HeN nu/nu (H-2k) mice into young MRL/MP-lpr/lpr (MRL/l; H-2k) mice (less than 1.5 mo) prevented the development of autoimmune diseases and characteristic thymic abnormalities in the recipient mice. When female MRL/1 (greater than 2 mo) or male BXSB (H-2b) mice (9 mo) with autoimmune diseases and lymphadenopathy were lethally irradiated and then reconstituted with allogeneic bone marrow cells from young BALB/c nu/nu (H-2d) mice (less than 2 mo), the recipients survived for more than 3 mo after the bone marrow transplantation and showed no graft-versus-host reaction. Histopathological study revealed that lymphadenopathy disappeared and that all evidence of autoimmune disease either was prevented from developing or was completely corrected even after its development in such mice. All abnormal T-cell functions were restored to normal. The newly developed T cells were found to be tolerant of both bone marrow donor-type (BALB/c) and host-type (MRL/1 or BXSB) major histocompatibility complex (MHC) determinants. Therefore, T-cell dysfunction in autoimmune-prone mice can be associated with both the involutionary changes that occur in the thymus of the autoimmune-prone mice and also to abnormalities that reside in the stem cells. However, normal stem cells from BALB/c nu/nu donors can differentiate into normal functional T cells even in mice whose thymus had undergone considerable involution, as in the case of BXSB or MRL/1 mice in the present studies. These findings suggest that marrow transplantation may be a strategy ultimately to be considered as an approach to treatment of life-threatening autoimmune diseases in humans. T-cell dysfunction in autoimmune-prone mice previously attributed to involutionary changes that occur in the thymus of these mice may instead be attributed to abnormalities that basically reside in the stem cells of the autoimmune-prone mice.

Full text

PDF
2483

Images in this article

2484Image
on p.2484
2484Image
on p.2484
2484Image
on p.2484
2484Image
on p.2484

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aizawa S., Sado T., Muto M., Kubo E. Immunology of fully H-2 incompatible bone marrow chimeras induced in specific-pathogen-free mice: evidence for generation of donor- and host-H-2 restricted helper and cytotoxic T cells. J Immunol. 1981 Dec;127(6):2426–2431. [PubMed] [Google Scholar]
  2. Andrews B. S., Eisenberg R. A., Theofilopoulos A. N., Izui S., Wilson C. B., McConahey P. J., Murphy E. D., Roths J. B., Dixon F. J. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med. 1978 Nov 1;148(5):1198–1215. doi: 10.1084/jem.148.5.1198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cantor H., McVay-Boudreau L., Hugenberger J., Naidorf K., Shen F. W., Gershon R. K. Immunoregulatory circuits among T-cell sets. II. Physiologic role of feedback inhibition in vivo: absence in NZB mice. J Exp Med. 1978 Apr 1;147(4):1116–1125. doi: 10.1084/jem.147.4.1116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Datta S. K., Manny N., Andrzejewski C., André-Schwartz J., Schwartz R. S. Genetic studies of autoimmunity and retrovirus expression in crosses of New Zealand black mice I. Xenotropic virus. J Exp Med. 1978 Mar 1;147(3):854–871. doi: 10.1084/jem.147.3.854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. DeHeer D. H., Edgington T. S. Evidence for a B lymphocyte defect underlying the anti-X anti-erythrocyte autoantibody response of NZB mice. J Immunol. 1977 May;118(5):1858–1863. [PubMed] [Google Scholar]
  6. Dixon F. J. Murine lupus--an overview. Arthritis Rheum. 1982 Jul;25(7):721–725. doi: 10.1002/art.1780250702. [DOI] [PubMed] [Google Scholar]
  7. Fauci A. S., Dale D. C., Balow J. E. Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med. 1976 Mar;84(3):304–315. doi: 10.7326/0003-4819-84-3-304. [DOI] [PubMed] [Google Scholar]
  8. Gershwin M. E., Ikeda R. M., Kruse W. L., Wilson F., Shifrine M., Spangler W. Age-dependent loss in New Zealand mice of morphological and functional characteristics of thymic epithelial cells. J Immunol. 1978 Mar;120(3):971–979. [PubMed] [Google Scholar]
  9. Hahn B. H., Kantor O. S., Osterland C. K. Azathioprine plus prednisone compared with prednisone alone in the treatment of systemic lupus erythematosus. Report of a prospective controlled trial in 24 patients. Ann Intern Med. 1975 Nov;83(5):597–605. doi: 10.7326/0003-4819-83-5-597. [DOI] [PubMed] [Google Scholar]
  10. Ikehara S., Pahwa R. N., Fernandes G., Hansen C. T., Good R. A. Functional T cells in athymic nude mice. Proc Natl Acad Sci U S A. 1984 Feb;81(3):886–888. doi: 10.1073/pnas.81.3.886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Israel-Biet D., Noel L. H., Bach M. A., Dardenne M., Bach J. F. Marked reduction of DNA antibody production and glomerulopathy in thymulin (FTS-Zn) or cyclosporin A treated (NZB X NZW) F1 mice. Clin Exp Immunol. 1983 Nov;54(2):359–365. [PMC free article] [PubMed] [Google Scholar]
  12. Izui S., McConahey P. J., Theofilopoulos A. N., Dixon F. J. Association of circulating retroviral gp70-anti-gp70 immune complexes with murine systemic lupus erythematosus. J Exp Med. 1979 May 1;149(5):1099–1116. doi: 10.1084/jem.149.5.1099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Jyonouchi H., Kincade P. W., Good R. A., Fernandes G. Reciprocal transfer of abnormalities in clonable B lymphocytes and myeloid progenitors between NZB and DBA/2 mice. J Immunol. 1981 Sep;127(3):1232–1235. [PubMed] [Google Scholar]
  14. Kincade P. W., Lee G., Fernandes G., Moore M. A., Williams N., Good R. A. Abnormalities in clonable B lymphocytes and myeloid progenitors in autoimmune NZB mice. Proc Natl Acad Sci U S A. 1979 Jul;76(7):3464–3468. doi: 10.1073/pnas.76.7.3464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Koike T., Nagasawa R., Nagata N., Shirai T. Specificity of mouse hybridoma antibodies to DNA. Immunol Lett. 1982 Feb;4(2):93–97. doi: 10.1016/0165-2478(82)90006-2. [DOI] [PubMed] [Google Scholar]
  16. Krakauer R. S., Waldmann T. A., Strober W. Loss of suppressor T cells in adult NZB/NZW mice. J Exp Med. 1976 Sep 1;144(3):662–673. doi: 10.1084/jem.144.3.662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Krown S. E., Coico R., Scheid M. P., Fernandes G., Good R. A. Immune function in fully allogeneic mouse bone marrow chimeras. Clin Immunol Immunopathol. 1981 May;19(2):268–283. doi: 10.1016/0090-1229(81)90069-6. [DOI] [PubMed] [Google Scholar]
  18. Kruisbeek A. M., Sharrow S. O., Mathieson B. J., Singer A. The H-2 phenotype of the thymus dictates the self-specificity expressed by thymic but not splenic cytotoxic T lymphocyte precursors in thymus-engrafted nude mice. J Immunol. 1981 Nov;127(5):2168–2176. [PubMed] [Google Scholar]
  19. McCombs C., Hom J., Talal N., Mishell R. I. Functional deficiency of splenic adherent cells in New Zealand black mice. J Immunol. 1975 Dec;115(6):1695–1699. [PubMed] [Google Scholar]
  20. Onoé K., Fernandes G., Good R. A. Humoral and cell-mediated immune responses in fully allogeneic bone marrow chimera in mice. J Exp Med. 1980 Jan 1;151(1):115–132. doi: 10.1084/jem.151.1.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Sekita K., Doi T., Muso E., Yoshida H., Kanatsu K., Hamashima Y. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus. Clin Exp Immunol. 1984 Mar;55(3):487–494. [PMC free article] [PubMed] [Google Scholar]
  22. Shiraki M., Fujiwara M., Tomura S. Long term administration of cyclophosphamide in MRL/1 mice. I. The effects on the development of immunological abnormalities and lupus nephritis. Clin Exp Immunol. 1984 Feb;55(2):333–339. [PMC free article] [PubMed] [Google Scholar]
  23. Slavin S. Successful treatment of autoimmune disease in (NZB/NZW)F1 female mice by using fractionated total lymphoid irradiation. Proc Natl Acad Sci U S A. 1979 Oct;76(10):5274–5276. doi: 10.1073/pnas.76.10.5274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Steinberg A. D., Raveche E. S., Laskin C. A., Miller M. L., Steinberg R. T. Genetic, environmental, and cellular factors in the pathogenesis of systemic lupus erythematosus. Arthritis Rheum. 1982 Jul;25(7):734–743. doi: 10.1002/art.1780250704. [DOI] [PubMed] [Google Scholar]
  25. Theofilopoulos A. N., Dixon F. J. Etiopathogenesis of murine SLE. Immunol Rev. 1981;55:179–216. doi: 10.1111/j.1600-065x.1981.tb00343.x. [DOI] [PubMed] [Google Scholar]
  26. Theofilopoulos A. N. Role of the thymus in murine lupus and cellular transfer of the disease. Arthritis Rheum. 1982 Jul;25(7):726–733. doi: 10.1002/art.1780250703. [DOI] [PubMed] [Google Scholar]
  27. Warner N. L., Moore M. A. Defects in hematopoietic differentiation in NZB and NZC mice. J Exp Med. 1971 Aug 1;134(2):313–334. doi: 10.1084/jem.134.2.313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Wofsy D., Kerger C. E., Seaman W. E. Monocytosis in the BXSB model for systemic lupus erythematosus. J Exp Med. 1984 Feb 1;159(2):629–634. doi: 10.1084/jem.159.2.629. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES